Why the study?
Does MMP-9 inhibition ameliorate pathogenesis and improve skeletal muscle regeneration in dystrophin-deficient mdx mice?
Population
Dystrophin-deficient mdx mice (animal model for Duchenne muscular dystrophy)
Comparison
Deletion of Mmp9 gene, pharmacological… vs Untreated mdx mice
Design
Preclinical
Authors
Loading...
MMP-9 inhibition merits further preclinical testing in muscular dystrophy; leaves open translation to human efficacy and safety.
Does MMP-9 inhibition ameliorate pathogenesis and improve skeletal muscle regeneration in dystrophin-deficient mdx mice?
Inhibition of MMP-9 ameliorates skeletal muscle pathogenesis and enhances regeneration in a mouse model of Duchenne muscular dystrophy, identifying it as a promising therapeutic target.
Li et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: